Laman Utama068270 • KRX
add
Celltrion Inc
Tutup sebelumnya
₩160,500.00
Julat hari
₩160,200.00 - ₩163,400.00
Julat tahun
₩150,400.00 - ₩200,952.39
Permodalan pasaran
36.28T KRW
Bilangan Purata
460.25K
Nisbah P/E
61.82
Hasil dividen
0.44%
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 841.91B | 14.24% |
Perbelanjaan pengendalian | 293.45B | 0.76% |
Pendapatan bersih | 108.67B | 384.28% |
Margin untung bersih | 12.91 | 324.67% |
Pendapatan bagi setiap syer | 529.00 | 414.31% |
EBITDA | 220.36B | 49.86% |
Kadar cukai berkesan | 44.58% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 970.72B | 5.45% |
Jumlah aset | 20.96T | 4.00% |
Jumlah liabiliti | 3.68T | 16.94% |
Jumlah ekuiti | 17.28T | — |
Syer tertunggak | 224.61J | — |
Harga kepada buku | 2.10 | — |
Pulangan pada aset | 1.78% | — |
Pulangan pada modal | 1.90% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 108.67B | 384.28% |
Tunai daripada operasi | 113.45B | 206.45% |
Tunai daripada pelaburan | -54.86B | -55.15% |
Tunai daripada pembiayaan | -243.49B | -242.88% |
Perubahan bersih dalam tunai | -167.36B | -191.58% |
Aliran tunai bebas | 226.51B | 169.09% |
Perihal
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Diasaskan
2002
Tapak web
Pekerja
2,391
